Sartorius | SRT3 - Loan Capital


Sartorius reported EUR3.65B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Akebia Therapeutics USD 24.75M 11.64M Jun/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
IQVIA Holdings USD 13.7B 284M Jun/2026
Moderna USD 597M 6M Jun/2026
Organon & Co USD 8.55B 75M Mar/2026
Revvity USD 2.63B 1.02M Jun/2026
Sartorius EUR 3.65B 311.1M Jun/2026
Tectonic Therapeutic USD 17K 26K Mar/2026
Viatris USD 11.61B 801.1M Jun/2026
Xeris Pharmaceuticals USD 188.81M 32.42M Jun/2026